Search

Your search keyword '"M, Siciliano"' showing total 119 results

Search Constraints

Start Over You searched for: Author "M, Siciliano" Remove constraint Author: "M, Siciliano" Publisher elsevier bv Remove constraint Publisher: elsevier bv
119 results on '"M, Siciliano"'

Search Results

2. Quadrupole and octupole collectivity in the semi-magic nucleus 80206Hg126

3. Applications of Rutherford backscattering analysis methods to nuclear physics experiments

9. A powerful combination measurement for exploring the fusion reaction mechanisms induced by weakly bound nuclei

10. The MUGAST-AGATA-VAMOS campaign: Set-up and performances

11. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance

13. Multifactor risk evaluation in patients who have eradicated HCV infection: an interim analysis in the PITER cohort

14. P.09.10 CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY PRESENT INCREASED CEREBRAL VASCULAR RESISTANCE, WHICH REMAINS UNCHANGED AFTER MEDICAL TREATMENT

15. Clinical impact of comorbidities in an Italian NAFLD cohort

16. Single crystalline β-Ga2O3 nanowires synthesized by thermal oxidation of GaSe layer

17. Centrality dependence of charged particle production at large transverse momentum in Pb–Pb collisions at sNN=2.76 TeV

18. Formation of α-TeO2 pearl-like microwires templated on porous microtubes through thermal oxidation of Te microtubes

19. Erratum to 'Rapidity and transverse momentum dependence of inclusive J/ψ production in pp collisions at s=7 TeV' [Phys. Lett. B 704 (5) (2011) 442]

20. Harmonic decomposition of two particle angular correlations in Pb–Pb collisions at sNN=2.76 TeV

22. The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution

23. Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)

24. Rapidity and transverse momentum dependence of inclusive J/ψ production in pp collisions at s=7 TeV

25. Two-pion Bose–Einstein correlations in central Pb–Pb collisions at sNN=2.76 TeV

26. Suppression of charged particle production at large transverse momentum in central Pb–Pb collisions at sNN=2.76 TeV

27. Transverse momentum spectra of charged particles in proton–proton collisions at s=900 GeV with ALICE at the LHC

28. P.09.23 COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT

29. P.09.30 NEW DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IMPACTS LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION

31. Characterisation and source apportionment of PM10 in an urban background site in Lecce

32. Single-crystalline Te microtubes: Synthesis and NO2 gas sensor application

33. Characterization of surface layers formed under natural environmental conditions on medieval glass from Siponto (Southern Italy)

34. The gut microbiota of cirrhotic patients with poor nutritional status: Preliminary evidences

35. Treatment failure to first-line direct antiviral (DAA) in HCV-related advanced liver disease: An Italian real-life urban setting

36. Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents

39. Biphasic Kinetics of HCV-RNA Decay is Accompanied by an even Faster Aminotransferases Normalization in All-Daa Treated Cirrhotic Patients: A Different Scenario from Interferon-Based Therapies

40. P.09.13: Hepatoma Arterial-Embolisation Prognostic Score Predicts Progression in Hepatocellular Carcinoma Treated by Radiofrequency Ablation Plus Transarterial Chemoembolization

41. P.10.7: The GUT Liver Axis after Liver Transplantation: Modification of Intestinal Permeability and Correlation with Infectious Complications and Patients Prognosis

42. Natural HCV resistance is common in Italy and differently associated to genotypes

43. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life

44. The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network

45. Improved virological outcomes and excellent safety profile in genotype 3 HCV-infected cirrhotic patients after an extended 24-weeks course of daclatasvir, sofosbuvir + ribavirin: insights from a real-life multicenter study

46. Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization

47. Accuracy of a Point Shear Wave Elastography Technique (ElastPQ) in the Non-Invasive Assessment of Liver Fibrosis in a Large Cohort of Liver Patients

48. Failure to First-Line Direct Antiviral (DAA) Treatment of HCV Infection in an Italian Real-Life Urban Setting

49. Dynamic Contrast Enhanced Ultrasound Perfusion Imaging and Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: A Feasibility Study

50. P1235 BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS

Catalog

Books, media, physical & digital resources